ArcticZymes Technologies ASA (FRA:B4V) Cyclically Adjusted Revenue per Share: €0.20 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:B4V ArcticZymes Technologies ASA FRA:B4V
80 GF Score
Price €1.75
GF Value €2.23
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share?

ArcticZymes Technologies ASA FRA:B4V -0.85% 80 Cyclically Adjusted Revenue per Share is €0.20 as of Mar. 2026. GuruFocus rates FRA:B4V with a GF Score™ of 80/100 and a GF Value™ of €2.23. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

ArcticZymes Technologies ASA's adjusted revenue per share for the three months ended in Mar. 2026 was €0.049. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.20 for the trailing ten years ended in Mar. 2026.

During the past 12 months, ArcticZymes Technologies ASA's average Cyclically Adjusted Revenue Growth Rate was 5.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of ArcticZymes Technologies ASA was 16.30% per year. The lowest was 4.60% per year. And the median was 10.50% per year.

As of today (2026-07-27), ArcticZymes Technologies ASA's current stock price is €1.745. ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €0.20. ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio of today is 8.73.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ArcticZymes Technologies ASA was 78.31. The lowest was 2.98. And the median was 12.05.


ArcticZymes Technologies ASA  (FRA:B4V) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.745/0.20
=8.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ArcticZymes Technologies ASA was 78.31. The lowest was 2.98. And the median was 12.05.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share Related Terms


ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.17 0.17 0.17 0.19

ArcticZymes Technologies ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.17 0.19 0.19 0.20

FRA:B4V vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio falls into.


FRA:B4V
80GF Score
ArcticZymes Technologies ASA FRA:B4V
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ArcticZymes Technologies ASA's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.049/141.0300*141.0300
=0.049

Current CPI (Mar. 2026) = 141.0300.

ArcticZymes Technologies ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.044 103.800 0.060
201609 0.055 104.200 0.074
201612 0.028 104.400 0.038
201703 0.048 105.000 0.064
201706 0.044 105.800 0.059
201709 0.039 105.900 0.052
201712 0.027 106.100 0.036
201803 0.038 107.300 0.050
201806 0.026 108.500 0.034
201809 0.061 109.500 0.079
201812 0.041 109.800 0.053
201903 0.034 110.400 0.043
201906 0.041 110.600 0.052
201909 0.050 111.100 0.063
201912 -0.026 111.300 -0.033
202003 0.035 111.200 0.044
202006 0.065 112.100 0.082
202009 0.037 112.900 0.046
202012 0.038 112.900 0.047
202103 0.083 114.600 0.102
202106 0.042 115.300 0.051
202109 0.048 117.500 0.058
202112 0.078 118.900 0.093
202203 0.097 119.800 0.114
202206 0.057 122.600 0.066
202209 0.058 125.600 0.065
202212 0.052 125.900 0.058
202303 0.055 127.600 0.061
202306 0.047 130.400 0.051
202309 0.053 129.800 0.058
202312 0.049 131.900 0.052
202403 0.049 132.600 0.052
202406 0.043 133.800 0.045
202409 0.038 133.700 0.040
202412 0.039 134.800 0.041
202503 0.039 136.100 0.040
202506 0.042 137.800 0.043
202509 0.044 138.500 0.045
202512 0.055 139.100 0.056
202603 0.049 141.030 0.049

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.20 mean?
ArcticZymes Technologies ASA (FRA:B4V) has a Cyclically Adjusted Revenue per Share of €0.20 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ArcticZymes Technologies ASA and its competitors.
Is ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share too high?
ArcticZymes Technologies ASA's current Cyclically Adjusted Revenue per Share is €0.20. Overall, ArcticZymes Technologies ASA has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share of €0.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ArcticZymes Technologies ASA and its competitors. ArcticZymes Technologies ASA's current Cyclically Adjusted Revenue per Share is €0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
ArcticZymes Technologies ASA (FRA:B4V) has a current Cyclically Adjusted Revenue per Share of €0.20. The stock's GF Value™ is €2.23, compared to a current price of €1.75 — trading 21.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.20. ArcticZymes Technologies ASA's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For ArcticZymes Technologies ASA (FRA:B4V), the current Cyclically Adjusted Revenue per Share is €0.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ArcticZymes Technologies ASA (FRA:B4V) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of €1.75 is trading 21.7% below its estimated GF Value™ of €2.23.

Key valuation signals for FRA:B4V:

  • Cyclically Adjusted Revenue per Share: €0.20
  • GF Value™: €2.23 vs. price of €1.75 (21.7% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the FRA:B4V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ArcticZymes Technologies ASA Business Description

Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
80GF Score

Get the complete analysis for FRA:B4V

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.75
Price
€2.23
GF Value